Ultromics designed EchoGo Amyloidosis to evaluate routine echocardiogram results for signs of cardiac amyloidosis. It received the FDA's breakthrough device designation back in 2023.

Vessel harvesting devices from Getinge have been recalled due to pieces breaking off during medical procedures. In some cases, surgeons were unable to retrieve the broken pieces. 

The Sensora platform, which includes multiple FDA-approved algorithms, has a new Category III CPT code.

Demand for inpatient and outpatient cardiology services is expected to increase significantly in the next decade, putting hospitals and health systems in a position where they need to plan ahead or risk falling behind. 

The Society of Cardiovascular Computed Tomography is cheering as a “huge win” the 2025 CMS payment increase for coronary CTA that more than doubles the current payment and “better aligns with the cost of providing CCTA services." The panel expects the move to bring an increase in CT utilization, more adoption with financial sustainability and greater access in currently underutilized areas.

Six multispecialty cardiovascular societies have called on CMS to approve Medicare payments for tricuspid transcatheter edge-to-edge repair (T-TEER).

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."